跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Budesonide Nasal spray suspension 64mcg - HSA Drug Approval Details
Approvals
/
HSA
/
Budesonide Nasal spray suspension 64mcg
Approved
THERAPEUTIC
Budesonide Nasal spray suspension 64mcg
Laboratorio Aldo-Union S.L.
🇸🇬 Health Sciences Authority
Approval Date
Oct 11, 2011
Approval ID
6bc83170e134cb84
Company
Laboratorio Aldo-Union S.L.
Type
Therapeutic
Approval Details
Approval Id
6bc83170e134cb84
Drug Name
Budesonide Nasal spray suspension 64mcg
Product Name
Budesonide Nasal spray suspension 64mcg
Approval Number
SIN14029P
Approval Date
2011-10-11
Registrant
TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.
Licence Holder
TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.
Drug Type
Therapeutic
Forensic Classification
Prescription Only
Dosage Form
SPRAY, SUSPENSION
Route Of Administration
NASAL
Atc Code
R01AD05
Atc Item Name
budesonide
Pharma Manufacturer Name
TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.
Company Detail Path
/organization/teva-pharmaceutical-investments-singapore-pte-ltd
Active Ingredients
Budesonide micronized
64.0 mcg/dose
Budesonide micronized
64.0 mcg/dose
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Oct 11, 2011
Approval ID
6bc83170e134cb84
Type
Therapeutic
Back to HSA Approvals